Diazyme Laboratories, Inc.

Home
United States
Poway, CA
Diazyme Laboratories, Inc.

Diazyme is a clinical chemistry reagent manufacturer that develops IVD assays for use on conventional open channel automated chemistry platforms.

08/10/2026

ADLM 2026 Recap: Thank You, Anaheim

ADLM 2026 in Anaheim was an energizing week for the Diazyme team! We were grateful for the chance to meet with so many laboratory and diagnostics professionals, share our latest developments, and hear directly from the people using our solutions every day.

Throughout the meeting, our booth was a hub for:
• Demonstrations of Diazyme’s specialty assays and analyzer solutions
• Conversations about workflow efficiency, assay performance, and future needs
• New connections and renewed partnerships across the clinical diagnostics community

To everyone who visited, asked questions, or explored new ways to collaborate with Diazyme, we appreciate your engagement and insights. Your feedback helps guide our ongoing work to deliver innovative, accessible diagnostic solutions for laboratories worldwide.

Want to continue the conversation or learn more?
🔗 https://bit.ly/4wbso48

07/27/2026

🎉 ADLM 2026 kicks off tomorrow!

We’re ready to meet you, share what’s new at Diazyme, and dive into the future of diagnostics together.

📍 Visit Booth #1923 and follow us for daily show highlights!

Reserve a meeting here: https://bit.ly/3SEnq1V

07/24/2026

We're excited to share that Cincinnati Children's Hospital Medical Center will present a poster featuring the clinical validation of the Diazyme MMP-7 Assay as a non-invasive screening tool to help rule out biliary atresia in newborns and infants.

• Poster: A-347
• Tuesday, July 28, 2026
• 1:30 – 2:30 pm

The presentation highlights the assay's analytical performance and its potential to support efficient, cost-effective screening in clinical laboratories.

We look forward to seeing you at ADLM 2026! Learn more: https://bit.ly/4yAA1DO

07/23/2026

We're pleased to announce that Diazyme's Lp(a) Molarity Assay is now Health Canada Registered.

This milestone expands access to standardized Lp(a) testing, providing clinical laboratories with a reliable solution for measuring lipoprotein(a) in nmol/L to support cardiovascular risk assessment.

Learn more about our Lp(a) Molarity Assay: https://bit.ly/4dRf79P

07/22/2026

Join the Diazyme Team

Be part of a team driven by innovation, collaboration, and a shared commitment to advancing diagnostic solutions.

Explore opportunities to grow your career and make an impact with Diazyme.

Explore our Career page -->https://bit.ly/4stQ0j8

07/20/2026

We’re one week away from the biggest lab medicine event of the year — ADLM 2026!

Make plans to visit Diazyme at Booth #1923 and explore our latest innovations in diagnostics and laboratory automation.

🧪 Educational sessions, featured products, and live demos await.

Reserve a meeting here: https://bit.ly/3SEnq1V

07/16/2026

FEATURED AT ADLM: Meet the DZ-Lite c270

Key features include:
• Up to 270 tests per hour
• Supports 1,2,3 & 4-Reagent assays
• Small Laboratory Footprint
• Automated cuvette washing and waste management

With a test menu of over 110 assays, the DZ Lite c270 delivers the performance and reliability needed for today’s busy labs—all in a space-saving footprint.

🔎 See it live at ADLM Booth #1923
Reserve a meeting here: https://bit.ly/3SEnq1V

07/14/2026

☀️ This summer, keep vitamin D levels in focus.

Diazyme’s EZ Vitamin D Assay is the first—and only—2 reagent, latex enhanced immunoturbidimetric test compatible with mainstream clinical chemistry analyzers—no specialty instrumentation required
🔬 Technical Highlights:
• Fully automated, no pre treatment or dilution
• Rapid turnaround: results in under 10 minutes
• Robust precision

Equip your lab with a reliable, fast, and cost effective solution for routine vitamin D screening.

🔬 Learn more at ADLM Booth #1923!
Reserve a meeting here: https://bit.ly/3SEnq1V

07/08/2026

The PLAC® Test helps support cardiovascular risk assessment by measuring Lp-PLA2 activity, a vascular-specific inflammatory marker associated with plaque instability.

Designed for clinical laboratory use, the PLAC Test provides a valuable tool to help identify hidden cardiovascular risk beyond traditional lipid markers.

Learn more about how PLAC testing supports better insight into cardiovascular health: https://bit.ly/4gLKANN

07/06/2026

Elevating Lipid Diagnostics with Diazyme's Lp(a) Assay
At Diazyme Laboratories, we’re committed to supporting the advancement of cardiovascular diagnostics with solutions that deliver accuracy, reliability, and clinical relevance. Our Lipoprotein (a) [Lp(a)] Assay is designed to provide dependable results that are essential for evaluating independent cardiovascular risk, particularly in individuals with a family history of premature heart disease.

Key advantages of Diazyme’s Lp(a) Assay:
• Reports in both mg/dL and nmol/L to align with current clinical recommendations
• Fully automated and compatible with most chemistry analyzers
• Wide measuring range and excellent precision
• Minimal interference from triglycerides, bilirubin, hemoglobin, and ascorbic acid

As lipid testing standards continue to evolve, Diazyme remains focused on equipping laboratories with solutions that enhance clinical decision-making and support proactive cardiovascular care.

Learn more: https://bit.ly/4apLmw7

Address

12889 Gregg Court
Poway, CA
92064

Website

http://www.diazyme.com/

Alerts

Be the first to know and let us send you an email when Diazyme Laboratories, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your business to be the top-listed Engineering Company in Poway?